AGE AND BODY MASS INDEX IN TYPE I ENDOMETRIAL CANCER GRADE
Downloads
Highlights:
1. The major risk factors for type I endometrial cancer, namely age and obesity, play a major role in the increase in this case and are thought to be related to the grade in these cancer patients.
2. Type I endometrial cancer patients at Dr. Soetomo General Academic Hospital 2019-2020 are dominated by patients diagnosed at the age of 56-65 years, having an overweight body mass index (23-24.9 kg/m2).
3. The patient's age and body mass index did not correlate with endometrial cancer type I grade.
Abstract
Background: The increase in obesity and life expectancy has contributed to type I endometrial cancer cases worldwide. Increased risk factors play a role in the increase of these cases. Objectives: To determine the relationship between age and BMI with the cancer grade. Material and Method: This research was a cross-sectional study. The data were obtained from the patient's medical records. The sampling technique was total sampling. The analysis used was Spearman Rho correlation test for the relationship between age and BMI with cancer grade. Results: This study recorded 54 patients with type I endometrial cancer in Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from 2019 to 2020. The patients were from the age group 56-65 years 25 patients (46.30%), 46-55 years 17 patients (31.48%), 36-45 years 8 patients (14.81%), 26-35 years 2 patients (3.7%), and >65 years 2 patients (3.7%). For BMI, the patients were overweight (23-24.9 kg/m2) 21 patients (38.89%), normal (18.5-22.9 kg/m2) 14 patients (25.93%), obesity (25-29.9 kg/m2) 12 patients (22.22%), and obesity II (≥30 kg/m2) 7 patients (12.96%). For grade, grade III were 22 patients (40.75%), grade II 20 patients (37.04%), and grade I 12 patients (22.22%). There was a weak, insignificant positive correlation between age with grade (Ï=0.116, 0.405>α=0.05) and a weak, insignificant negative correlation between BMI with grade (Ï=-0.206, 0.135>α=0.05). Conclusion: A total of 54 patients with type I endometrial cancer at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from 2019-2020 aged 56-65 years and overweight (23-24.9 kg/m2) with grade III cancer. The patient's age and BMI did not correlate with the patient's grade.
Askandar, B. Saputra, A.A., 2021. Relationship between CA-125 levels and extrauterine spread in endometrial cancer endometrioid type at Dr. Soetomo General Hospital Surabaya. Indonesian Journal of Cancer, 15(2): 60. doi: 10.33371/ijoc.v15i2.757.
Baracos, V. Martin, L. Guttridge, D.C. Fearon, K.C.H. Korc, M.E., 2018. Cancer-associated cachexia. Nature Reviews Disease Primers, 4(1): 17105. doi: 10.1038/nrdp.2017.105.
Boroń, D. Nowakowski, R. Grabarek, B.O. Zmarzly, N. Oplawski, M., 2021. Expression pattern of leptin and its receptors in endometrioid endometrial cancer. Journal of Clinical Medicine, 10(13): 2787. doi: 10.3390/jcm10132787.
Dinkelspiel, H.E. Wright, J.D. Lewin, S.N. Herzog, T.J., 2013. Contemporary clinical management of endometrial cancer. Obstetrics and Gynecology International, 2013: 1–11. doi: 10.1155/2013/583891.
Donkers, H. Bekkers, R. Massuger, R. Galaal, K., 2020. Socioeconomic deprivation and survival in endometrial cancer: The effect of BMI. Gynecologic Oncology, 156(1): 178–184. doi: 10.1016/j.ygyno.2019.10.030.
Flak, J.N. Myers, M.G., 2016. Minireview: CNS mechanisms of leptin action. Molecular Endocrinology, 30(1): 3–12. doi: 10.1210/me.2015-1232.
Gao, Y. Dai, X. Chen. L. Lee, A.C. Tong, M. Wise, M. et al., 2016. Body mass index is positively associated with endometrial cancer in Chinese women, especially prior to menopause. Journal of Cancer, 7(9): 1169–1173. doi: 10.7150/jca.15037.
Gao, Y. Dai, X. Lee, A.C. Wise, M.R. Shen, F. Chen, W., 2018. Body mass index is negatively associated with endometrial cancer stage, regardless of subtype and menopausal status. Journal of Cancer, 9(24): 4756–4761. doi: 10.7150/jca.21137.
He, S. Sharpless, N.E., 2017. Senescence in health and disease. Cell, 169(6): 1000–1011. doi: 10.1016/j.cell.2017.05.015.
International Agency for Research on Cancer., 2020. Cancer today, World Health Organization.
Khazaei, Z. Dehkordi, A.H. Amiri, M. Adineh, A.H. Sohrabivafa, M. Darvishi, I., 2018. The incidence and mortality of endometrial cancer and its association with body mass index and human development index in Asian population. World Cancer Research Journal, 5(4): e1174. doi: 10.32113/wcrj_201812_1174.
Khouri, O.R. Frey, M.K. Musa, F. Muggia, F. Lee, J. Boyd, L. et al., 2019. Neoadjuvant chemotherapy in patients with advanced endometrial cancer. Cancer Chemotherapy and Pharmacology, 84(2): 281–285. doi: 10.1007/s00280-019-03838-x.
Lodato, M.A.Walsh, C.A., 2019. Genome aging: somatic mutation in the brain links age-related decline with disease and nominates pathogenic mechanisms. Human Molecular Genetics, 28(R2): R197–R206. doi: 10.1093/hmg/ddz191.
Mardiah, H. Ginting, R.N.A. Ramadhany, H. Sitorus, E.R.D., 2021. Correlation between age and Body Mass Index (BMI) with histopathological features of breast cancer patients in RSUP Haji Adam Malik Medan. Indonesian Journal of Cancer, 15(2): 46. doi: 10.33371/ijoc.v15i2.708.
National Cancer Institute., 2022. Cancer stat facts: Uterine cancer, National Institute of Health.
Nevadunsky, N.S., Van Arsadale, A. Strickler, H. Moadel, A. Kaur, G. Levitt, J. et al., 2014. Obesity and age at diagnosis of endometrial cancer. Obstetrics & Gynecology, 124(2): 300–306. doi: 10.1097/AOG.0000000000000381.
Nuryanto, K.H. Fransiska, S., 2019. Diagnostic value of transvaginal ultrasonography to determined degree of myometrium invasion in endometrial cancer. Indonesian Journal of Obstetrics and Gynecology: 213–218. doi: 10.32771/inajog.v7i3.836.
Onstad, M.A. Schmandt, R.E. Lu, K.H., 2016. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. Journal of Clinical Oncology, 34(35): 4225–4230. doi: 10.1200/JCO.2016.69.4638.
Pokharna, S., 2017. Epidemiology and prevention of endometrial carcinoma. Springer New York.
Rachmi, C.N. Li, M. Alison Baur, L., 2017. Overweight and obesity in Indonesia: Prevalence and risk factors”a literature review. Public Health, 147: 20–29. doi: 10.1016/j.puhe.2017.02.002.
Rahestyningtyas, E. Mulawardhana, P. Lesmana, T., 2019. Abdominal skin metastasis in endometrial cancer. Majalah Obstetri & Ginekologi, 27(2): 84. doi: 10.20473/mog.V27I22019.84-89.
Reho, J.J. Rahmouni, K., 2017. Oxidative and inflammatory signals in obesity-associated vascular abnormalities. Clinical Science, 131(14): 1689–1700. doi: 10.1042/CS20170219.
Rodriguez, A.C. Blanchard, Z. Maurer, K.A. Gertz, J., 2019. Estrogen signaling in endometrial cancer: a key oncogenic pathway with several open questions. Hormones and Cancer, 10(2–3): 51–63. doi: 10.1007/s12672-019-0358-9.
Sofyan, N. Sudiana, I.K. Askandar, B., 2020. Profile of endometrial cancer patients in the third referral hospital in Surabaya based on known risk factors. Biomolecular and Health Science Journal, 3(2),67-70.
Soslow, R.A. Tornos, C. Park, K.J. Malpica, A. Matias-Guiu, X. Oliva, E. et al., 2019. Endometrial carcinoma diagnosis. International Journal of Gynecological Pathology, 38: S64–S74. doi: 10.1097/PGP.0000000000000518.
Statistics Indonesia., 2021. Angka Harapan Hidup (AHH) menurut provinsi dan jenis kelamin (tahun), 2019-2021.
Stubert, J. Gerber, B., 2016. Current issues in the diagnosis and treatment of endometrial carcinoma. Geburtshilfe und Frauenheilkunde, 76(02): 170–175. doi: 10.1055/s-0035-1558230.
The Ministry of Health Republic of Indonesia (2018a) 1 dari 4 penduduk dewasa mengalami obesitas.
The Ministry of Health Republic of Indonesia. 2018b. Laporan Riskesdas (Provinsi) 2018.
Travaglino, A. Raffone, A. Gencarelli, A. Mollo, A. Guida, M. Insabato, L. et al., 2020. TCGA classification of endometrial cancer: The place of carcinosarcoma. Pathology & Oncology Research, 26(4): 2067–2073. doi: 10.1007/s12253-020-00829-9.
WilczyÅ„ski, M. Danielska, J. WilczyÅ„ski, J., 2016. An update of the classical Bokhman's dualistic model of endometrial cancer. Menopausal Review, 2: 63–68. doi: 10.5114/pm.2016.61186.
World Cancer Research Fund International., 2020. Endometrial cancer, World Cancer Research Fund International.
World Health Organization., 2021. Obesity and overweight, World Health Organization.
Zhang, S. Gong, T.T. Liu, F.H. Jiang, Y.T. Sun, H. Ma, X.X. et al., 2019. Global, regional, and national burden of endometrial cancer, 1990–2017: results from the global burden of disease study, 2017. Frontiers in Oncology, 9. doi: 10.3389/fonc.2019.01440.
Copyright (c) 2022 Gilang Adi Firmansyah, Dyah Fauziah, Brahmana Askandar Tjokroprawiro
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. The journal allows the author(s) to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution 4.0 International License (CC-BY).
